Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026

Rhea-AI Summary

Vericel (NASDAQ:VCEL) will report first-quarter 2026 financial results on Thursday, May 7, 2026. Management will host a conference call and live webcast at 8:30 a.m. ET to discuss results and business highlights.

Presentation slides will be available on the Investor Relations website and a replay of the webcast will be accessible until May 7, 2027. Telephone participants can dial the provided U.S. and international numbers and enter passcode 244506.

News Market Reaction – VCEL

+0.09%

+0.09% Session close to close

In the Apr 23 session, VCEL gained 0.09%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement sets the timing for Vericel’s first-quarter 2026 results and provides access detai...

Analysis

This announcement sets the timing for Vericel’s first-quarter 2026 results and provides access details for the webcast and replay lasting until May 7, 2027. In recent months, the company has highlighted strong 2025 revenue of $276.3M, high gross margins, and expanded manufacturing capacity. Investors may focus on how upcoming Q1 results track against 2026 guidance and prior growth trends, using the scheduled call to assess management’s commentary on execution and outlook.

Key Figures

Earnings release date: May 7, 2026 Conference call time: 8:30 a.m. ET Webcast replay duration: Until May 7, 2027 +3 more

6 metrics

Earnings release date May 7, 2026 Scheduled first-quarter 2026 financial results announcement

Conference call time 8:30 a.m. ET Time of Q1 2026 results conference call and webcast

Webcast replay duration Until May 7, 2027 Availability of replay of the earnings call webcast

US dial-in number 800-330-6730 Telephone access for the earnings conference call

International dial-in +1-312-471-1351 International access for the earnings conference call

Call passcode 244506 Passcode required to join the Q1 2026 call by phone

Previous Earnings date Reports

1 past event · Latest: Feb 12 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 12	Earnings date notice	Neutral	-1.9%	Announcement of Q4 and full-year 2025 results date and webcast details.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Only one prior earnings date event in the last six months, which saw a modest -1.91% move after the announcement.

Recent Company History

Recent news flow has highlighted Vericel’s operational and financial strength, including FDA approval for commercial MACI manufacturing in Burlington, a BARDA contract valued up to $197 million for NexoBrid, and strong 2025 financial results with total revenue of $276.3M. Within this backdrop, the prior earnings date announcement on Feb 12, 2026 led into full-year results released on Feb 26, 2026. Today’s first-quarter 2026 earnings date fits into that ongoing cadence of scheduled financial updates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMBRIDGE, Mass., April 23, 2026 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that the Company will report its first-quarter 2026 financial results on Thursday, May 7, 2026. Vericel’s management will host a conference call and webcast at 8:30 a.m. ET to discuss its financial results and business highlights.

The live webcast can be accessed on the Investor Relations section of the Vericel website at http://investors.vcel.com/events-presentations. Presentation slides for the conference call will be available on the webcast and on the website. A replay of the webcast will be available until May 7, 2027.

To participate by telephone, dial 800-330-6730 or +1-312-471-1351 if connecting from outside the U.S. When connected, please use passcode: 244506.

About Vericel Corporation
Vericel is a leading provider of advanced therapies for the sports medicine and severe burn care markets. The Company combines innovations in biology with medical technologies, resulting in a highly differentiated portfolio of innovative cell therapies and specialty biologics that repair injuries and restore lives. Vericel markets three products in the United States. MACI^® (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage defects of the knee with or without bone involvement in adults. Epicel^® (cultured epidermal autografts) is a permanent skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body surface area. Vericel also holds an exclusive license for North American rights to NexoBrid^® (anacaulase-bcdb), a biological orphan product containing proteolytic enzymes, which is indicated for eschar removal in adults and pediatric patients with deep partial-thickness and/or full-thickness burns. For more information, please visit www.vcel.com. Epicel and MACI are registered trademarks of Vericel Corporation. NexoBrid is a registered trademark of MediWound Ltd. and is used under license to Vericel Corporation. © 2026 Vericel Corporation. All rights reserved.

Investor Contact:
Eric Burns
ir@vcel.com
+1 (734) 418-4411

FAQ

When will Vericel (VCEL) report its Q1 2026 results and how can I listen?

Vericel will report Q1 2026 results on May 7, 2026 at 8:30 a.m. ET. According to the company, investors can listen via live webcast on the Investor Relations site or join by telephone using the listed numbers and passcode 244506.

What is the webcast replay availability for Vericel (VCEL) Q1 2026 earnings?

A replay of the Vericel Q1 2026 webcast will be available until May 7, 2027. According to the company, the replay and presentation slides will remain accessible on the Investor Relations website for one year after the live event.

What phone numbers and passcode are provided for Vericel (VCEL) Q1 2026 call?

To join by telephone, dial 800-330-6730 (U.S.) or +1-312-471-1351 (outside U.S.) and use passcode 244506. According to the company, those numbers connect participants to the live conference call at 8:30 a.m. ET on May 7, 2026.

Where can I find the presentation slides for Vericel (VCEL) Q1 2026 results?

Presentation slides will be posted on the Investor Relations website and shown during the live webcast. According to the company, slides will be available on the webcast page and downloadable from the events and presentations section.

Will Vericel (VCEL) management discuss business highlights during the Q1 2026 call?

Yes, management will discuss financial results and business highlights during the call at 8:30 a.m. ET on May 7, 2026. According to the company, the conference call and webcast are intended to review results and recent corporate developments.